These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22544194)

  • 1. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
    Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
    Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
    Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
    Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
    Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
    Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
    Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
    PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
    Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
    BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
    Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.
    Daoni E; Kitur U; Parunga A; Ndenzako F; Lloyd A; Yu D
    Clin Infect Dis; 2012 May; 54 Suppl 4():S303-5. PubMed ID: 22544192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early warning indicators for HIV drug resistance in Malawi.
    Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
    Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
    HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
    Wadonda-Kabondo N; Hedt BL; van Oosterhout JJ; Moyo K; Limbambala E; Bello G; Chilima B; Schouten E; Harries A; Massaquoi M; Porter C; Weigel R; Hosseinipour M; Aberle-Grasse J; Jordan MR; Kabuluzi S; Bennett DE
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S355-61. PubMed ID: 22544203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
    Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
    PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
    Ma Y; Zhang F; Li H; Wu H; Zhang J; Ding Y; Zhao D; Fang H; Zhou S; Liu Z; Zhang L; Osborne C; Seguy N; Zhao Y
    Clin Infect Dis; 2012 May; 54 Suppl 4():S300-2. PubMed ID: 22544191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
    Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
    PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV drug resistance early warning indicators in Namibia for public health action.
    Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
    PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
    Wadonda-Kabondo N; Bennett D; van Oosterhout JJ; Moyo K; Hosseinipour M; Devos J; Zhou Z; Aberle-Grasse J; Warne TR; Mtika C; Chilima B; Banda R; Pasulani O; Porter C; Phiri S; Jahn A; Kamwendo D; Jordan MR; Kabuluzi S; Chimbwandira F; Kagoli M; Matatiyo B; Demby A; Yang C
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S362-8. PubMed ID: 22544204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the early warning indicators of HIV drug resistance surveillance system in Manicaland province, Zimbabwe.
    Marume A; Zikiti A; Chapoterera B; Maradzika J
    Afr J AIDS Res; 2019 Jul; 18(2):123-129. PubMed ID: 31282304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
    Dube NM; Tint KS; Summers RS
    Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.